Target intelligence / Profile preview

Ocular surface epithelium healing via growth factors and nutrients present in human serum

Molecular classification
Other (not a single molecule, receptor, or protein family), Mixture of growth factors, cytokines, vitamins, and proteins derived from human serum
01

Overview

This "target" does not refer to a single molecule or receptor but rather to the therapeutic approach of promoting ocular surface epithelium healing using the diverse array of growth factors and nutrients naturally present in human blood-derived products—most commonly autologous serum or platelet-rich plasma formulated as topical eye drops. These preparations contain many components found in natural tears—including EGF, TGF-beta, PDGF, NGF, IGF‑1—as well as vitamins A/E and other proteins that collectively stimulate cell proliferation/migration/differentiation while reducing inflammation on the damaged ocular surface. This strategy is used clinically to treat dry eye disease unresponsive to conventional therapy as well as persistent epithelial defects due to trauma or surgery. The mechanism involves mimicking natural tear composition while providing additional regenerative signals that facilitate wound closure and restore tissue integrity. However, this entry does not represent a discrete drug target but rather an entire class of biological mediators delivered together; thus it should not be considered a canonical molecular target. "AS contains numerous substances that also exist in normal tears... As such AS not only serves lubricating and antiinflammatory functions but it also has regenerative properties for healing the ocular surface." "The repair mechanism for corneal epithelial cell injuries encompasses migration proliferation... In recent years... it has become increasingly apparent that growth factors play a pivotal role..."

Other names
Human serum-derived ocular surface healingSerum eye drops-mediated epithelial repairGrowth factor-mediated corneal epithelial healingAutologous serum therapy for ocular surface
02

Mechanism of action

The therapeutic effect is mediated by the combined action of multiple growth factors and nutrients present in human serum. These include epidermal growth factor (EGF), transforming growth factor beta (TGF-beta), platelet-derived growth factor (PDGF), nerve growth factor (NGF), insulin-like growth factor 1 (IGF‑1), substance P, fibronectin, vitamins A/E. They promote epithelial cell migration, proliferation, differentiation, extracellular matrix remodeling, anti-inflammatory effects, and support for corneal nerves through activation of their respective receptors and downstream signaling pathways such as EGFR/PI3K/Akt/ERK/NF-kB.

03

Biological functions

Cell proliferationCell migrationTissue regenerationWound healingAnti-inflammationMaintenance of tissue homeostasis
04

Disease associations

Dry eye disease (DED)Corneal injury/ulcerationNeurotrophic keratitisOcular surface disorders (general)
05

Safety considerations

Potential contamination/infection risk during preparation or useVariability in composition between preparations/patientsLimited shelf life/refrigeration requirementsPossible immunologic reactions with allogenic products
06

Interacting drugs

Autologous serum eye drops

3 more in the full profile.

07

Biomarkers

There are no specific molecular biomarkers for patient selection; clinical diagnosis is based on signs/symptoms of ocular surface disease.Efficacy monitoring relies on improvement in clinical parameters such as corneal staining scores or tear film stability.

Beyond the preview

Go deeper on Ocular surface epithelium healing via growth factors and nutrients present in human serum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocular surface epithelium healing via growth factors and nutrients present in human serum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call